Your browser doesn't support javascript.
loading
Effectiveness of various COVID-19 vaccine regimens among 10.4 million patients from the National COVID Cohort Collaborative during Pre-Delta to Omicron periods - United States, 11 December 2020 to 30 June 2022.
Fu, Yuanyuan; Wu, Kaipeng; Wang, Zhanwei; Yang, Hua; Chen, Yu; Wu, Lang; Yanagihara, Richard; Hedges, Jerris R; Wang, Hongwei; Deng, Youping.
Afiliación
  • Fu Y; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.
  • Wu K; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.
  • Wang Z; Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA.
  • Yang H; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.
  • Chen Y; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.
  • Wu L; Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA.
  • Yanagihara R; Department of Pediatrics, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.
  • Hedges JR; Departments of Medicine and Surgery, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.
  • Wang H; Department of Medicine, University of Chicago, Chicago, IL, 60637, USA. Electronic address: hongwei-wang@boneandcancer.org.
  • Deng Y; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA. Electronic address: dengy@hawaii.edu.
Vaccine ; 41(42): 6339-6349, 2023 10 06.
Article en En | MEDLINE | ID: mdl-37741761

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos